Get started
Author

Vikas Bhardwaj

CCAT2 , a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer
2013 · Hui Ling, Riccardo Spizzo, et al. · Genome Research · 613
PDF
Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
2012 · Lauren Averett Byers, Jing Wang, et al. · Cancer Discovery · 565
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
2014 · Maria Angelica Cortez, David Valdecanas, et al. · Molecular Therapy · 205
Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer
2020 · Vikas Bhardwaj, Jun He · International Journal of Molecular Sciences · 91
PDF
Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
2021 · Aditi Jain, Vikas Bhardwaj · World Journal of Gastroenterology · 65
PDF
C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non–Small-Cell Lung Cancer Cells With Radiation-Induced c-Met–Expression
2012 · Vikas Bhardwaj, Yanai Zhan, et al. · Journal of Thoracic Oncology · 63
PDF
Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics.
2010 · Vikas Bhardwaj, Nisha Rizvi, et al. · PubMed · 61
Modulation of c‐Met signaling and cellular sensitivity to radiation: Potential implications for therapy
2013 · Vikas Bhardwaj, Tina Cascone, et al. · Cancer · 50
PDF
Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase
2020 · Neha Sharma, Alok Bhushan, et al. · Cancer & Metabolism · 46
PDF
Biochanin A reduces pancreatic cancer survival and progression
2013 · Vikas Bhardwaj, Satya Murthy Tadinada, et al. · Anti-Cancer Drugs · 45
Helicobacter pylori bacteria alter the p53 stress response via Erk-HDM2 pathway
2015 · Vikas Bhardwaj, Jennifer M. Noto, et al. · Oncotarget · 44
PDF
S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
2020 · Hua Shen, Gao-Chan Wang, et al. · Oncogene · 41
Abstract 4403: Differential cytotoxic effects of atorvastatin in human hepatocellular carcinoma and pancreatic adenocarcinoma cells
2011 · Maria B. Lai, Vikas Bhardwaj, et al. · Cancer Research · 38
Activation of NADPH oxidases leads to DNA damage in esophageal cells
2017 · Vikas Bhardwaj, Ravindran Caspa Gokulan, et al. · Scientific Reports · 32
PDF
Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation
2019 · Jun He, Weitao Liu, et al. · Toxicology and Applied Pharmacology · 27
Prevention of DNA damage in Barrett’s esophageal cells exposed to acidic bile salts
2016 · Vikas Bhardwaj, Andela Horvat, et al. · Carcinogenesis · 20
Proinflammatory Cytokines and Bile Acids Upregulate ΔNp73 Protein, an Inhibitor of p53 and p73 Tumor Suppressors
2013 · Elena Zaika, Vikas Bhardwaj, et al. · PLoS ONE · 13
PDF
Failure of Pancreatic Cancer Chemotherapy: Consequences of Drug Resistance Mechanisms
2012 · Vikas Bhardwaj, Satya Murthy, et al. · InTech eBooks · 7
PDF
Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity
2022 · Vikas Bhardwaj, Jun He, et al. · Medical Oncology · 6
Investigation of PARP1 as a therapeutic target in small cell lung cancer.
2012 · Lauren Averett Byers, Monique B. Nilsson, et al. · Journal of Clinical Oncology · 2
Abstract PO2-13-06: Analysis of Antibody Response to SV-BR-1-GM Therapeutic Vaccine in Breast Cancer Patients Using Human Protein Microarrays: Potential Correlations with Therapy Response
2024 · Miguel Lopez-Lago, Mingjin Chang, et al. · Cancer Research · 1
Su1824 Helicobacter pylori Alters p53 Stress Response Induced by Disruption of the Adherens Junctions
2015 · Vikas Bhardwaj, Jinxiong Wei, et al. · Gastroenterology · 1
Elevated Serum HGF Is Associated With Radioresistance and Local Recurrence in Non-Small Cell Lung Cancer
2013 · H.E. Soh, V. Bhardwaj, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Iodoacetate and 3-bromopyruvate modulate cell signaling to decrease the pancreatic cancer cell survival
2008 · Vikas Bhardwaj, Nisha Rizvi, et al. · Cancer Research · 1
863 A multifaceted genetically engineered whole-cell vaccine platform generates potent, broad, persistent, and effector-centric anti-tumor immunity across multiple cancer indications
2026 · Miguel Lopez-Lago, Pravin Kesarwani, et al. · Journal for ImmunoTherapy of Cancer
Works count: 57
Citation count: 2,038
H-index: 16
I10-index: 17
Year
Topic
Type